- €1.39bn
- €1.42bn
- €493.65m
- 65
- 48
- 66
- 65
Annual income statement for Faes Farma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 380 | 399 | 439 | 451 | 494 |
| Cost of Revenue | |||||
| Gross Profit | 240 | 252 | 282 | 297 | 327 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 293 | 305 | 337 | 348 | 387 |
| Operating Profit | 86.8 | 93.3 | 101 | 103 | 107 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 84.9 | 93 | 101 | 103 | 108 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 73.4 | 82.4 | 89.5 | 91.7 | 111 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 72.5 | 82.4 | 89.5 | 91.9 | 111 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 72.5 | 82.4 | 89.5 | 91.9 | 111 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.244 | 0.26 | 0.284 | 0.296 | 0.359 |
| Dividends per Share |